Auriga

Auriga has lowered the price target on MedAssets (NASDAQ: MDAS) from $21 to $19 and maintains its Buy rating.

Auriga has upgraded Waters Corporation (NYSE: WAT) from Neutral to Buy and reiterates its $103 price target.

Auriga is out with its report today on SunPower (NASDAQ: SPWRA), maintaining Sell. In its report, Auriga writes, "In view of continued weakness in fundamentals and a subpar business model, we maintain our Sell rating and $14 price target." At the time of posting, shares of SPWRA were trading at $...

Auriga is out with its report today on Myriad Genetics (NASDAQ: MYGN), lowering its PT to $21 from $25. In its report, Auriga writes, "In our view, MYGN is making the necessary and proper investments, however the top line pay off is not likely to materialize until FY13. As such, we are maintaining...

Auriga is out with its report today on Dell (NASDAQ: DELL), maintaining Buy. In its report, Auriga writes, "We continue to believe Dell can grow its top-line roughly in-line with overall IT spending as it transforms itself into a full-service enterprise vendor over the next several years. The real...

Auriga upgraded its EMC (NYSE: EMC) rating from Hold to Buy. On Friday, EMC lost 2.34% of its value to finish the day at $22.99. Its shares continued to slide in today's pre-market trading, falling 2.13% to stand around $22.50.

Auriga upgraded its NetApp (NASDAQ: NTAP) rating from Hold to Buy. On Friday, NTAP lost 3.37% of its value to finish the day at $41.87.

Auriga is out with its report today on MEMC Electronic Materials (NYSE: WFR), maintaining Buy. In its report, Auriga writes, "While solar wafer business is coping with the expected pricing pressure, semi wafers and SunEdison business have shown operational improvement and will likely gain further...

Auriga has upgraded Allscripts (NASDAQ: MDRX) from Hold to Buy and has established a $22 price target.

Auriga is out with its report today on Intervac (NASDAQ: IVAC), maintaining Buy. In its report, Auriga writes, "While 2011 is clearly going to be a rough year for the core HDD equipment business, we believe it will throw off decent cash flow over time. Meanwhile, potentially large long term growth...

Auriga is out with its report today on eResearch (NYSE: ERT), lowering its PT from $10 to $9. In its report, Auriga writes, "Our new target (down from $10) is based primarily on some modest multiple compression in the Contract Research Organization group. We use a combination of P/E, EV/EBITDA and...

Auriga is out with its report today on MedAssets (NASDAQ: MDAS), reiterating Buy. In its report, Auriga writes, "In our view, MDAS' narrowed EPS range of $0.96-$1.02 on albeit a slightly weaker revenue guide is impressive enough to offset the tremendous negative sentiment heading into earnings. We...

Auriga is out with its report today on MEMC Electronic Materials (NYSE: WFR), maintaining Buy. In its report, Auriga writes, "While operational improvement will steadily gain traction into 2H11 and beyond, we believe MEMC valuation is compelling and cannot be ignored by any long-term investor."...

Auriga has published a report on McKesson (NYSE: MCK) reiterating the Buy rating and lowering the price target by one dollar. In the report, Auriga wrote, "We are reiterating our BUY rating on McKesson (MCK) following a strong start to FY12 in which results edged out expectations. Strength in...

Auriga has published a report on Computer Programs & Systems Inc. (NASDAQ: CPSI) raising the price target to $78. In the report, Auriga wrote, "We are maintaining our HOLD rating on CPSI (CPSI), raising our price target to $78 (from $60 ) while crediting the company with outstanding Q2...